A Retrospective Study of Anti-Vascular Endothelial Growth Factor (VEGF) Injections for Retinal Vein Occlusion or Diabetic Macular Edema

Study Identifier
GMA-OZU-13-598
CT.gov Identifier
NCT01918371
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Macular Edema
    • Study Drug
  • Anti-VEGF
    • Phase
    N/A
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Macular edema in the study eye due to RVO or DME * Received an anti-VEGF injection in the study eye on or after June 2010 for RVO and on or after August 2012 for DME
    Exclusion Criteria:
    * None

    Protocol Summary

    This retrospective data review study will evaluate anti-VEGF injections for retinal vein occlusion (RVO) or diabetic macular edema (DME).

    Study Locations

    Location
    Status
    Location
    San Antonio, Texas, United States
    Status
    Not applicable